Citation Tools

Download PDFPDF

733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy

Download to a citation manager

Cite this article as:
Gjini E, Trillo-Tinoco J, Browne A, et al
733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy